Neuphoria Therapeutics Inc (NEUP) — Cash Flow Quality Index
Neuphoria Therapeutics Inc (NEUP) has a Cash Flow Quality Index of -3.45x as of December 2025. Operating cash flow of $-6.44 Million is below net income of $1.86 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore NEUP operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Neuphoria Therapeutics Inc Cash Flow Quality Index (2014–2014)
Historical Cash Flow Quality Index for Neuphoria Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Neuphoria Therapeutics Inc cash flow conversion.
Annual Cash Flow Quality Index for Neuphoria Therapeutics Inc (2014–2014)
Year-by-year earnings quality comparison for Neuphoria Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2014 | -4.28x | $-12.91 Million | $3.02 Million | — |